Maximal Respiratory Muscle Strength in Singaporean Adults: Normative Reference Values and Predictive Models from a Cross-Sectional Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Ethics
2.2. Sample Size Calculations and Participant Recruitment
2.3. Data Collection
2.3.1. Chest Circumferences
2.3.2. Waist–Hip Ratio
2.3.3. Maximum Inspiratory and Expiratory Pressure Assessment
2.4. Statistical Analysis
3. Results
3.1. Participants
3.2. MIP and MEP Values
3.3. Correlation with MIP and MEP
3.4. Prediction of MIP and MEP
4. Discussion
4.1. Gender and Age Differences for MIP and MEP
4.2. Correlations of MIP and MEP
4.3. Regression Equations and Clinical Utility
4.4. Limitations
4.5. Future Directions
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| MIP | Maximal Inspiratory Pressure |
| MEP | Maximal Expiratory Pressure |
| NRV | Normative Reference Values |
| BMI | Body Mass Index |
| FVC | Forced Vital Capacity |
| FEV1 | Forced Expiratory Volume at the end of first second |
| IQR | Interquartile Range |
| PAR-Q | Physical Activity Readiness Questionnaire for Everyone |
| FEV1/FVC% | Percentage of the FVC expired in one second |
| PEF | Peak Expiratory Flow |
| PEF25–75% | Peak Expiratory Flow at 25% and 75% of the pulmonary volume |
| CI | Confidence Interval |
| SD | Standard Deviation |
| MOE | Margin of Error |
| ATS/ERS | American Thoracic Society and European Respiratory Society |
References
- American Thoracic Society/European Respiratory Society. ATS/ERS Statement on Respiratory Muscle Testing. Am. J. Respir. Crit. Care Med. 2002, 166, 518–624. [Google Scholar] [CrossRef] [PubMed]
- Pessoa, I.M.B.S.; Parreira, V.F.; Fregonezi, G.A.F.; Sheel, A.W.; Chung, F.; Reid, W.D. Reference Values for Maximal Inspiratory Pressure: A Systematic Review. Can. Respir. J. 2014, 21, 982374. [Google Scholar] [CrossRef]
- Bairapareddy, K.C.; Augustine, A.; Alaparthi, G.K.; Hegazy, F.; Shousha, T.M.; Ali, S.A.; Nagaraja, R.; Chandrasekaran, B. Maximal respiratory pressures and maximum voluntary ventilation in young arabs: Association with anthropometrics and physical activity. J. Multidiscip. Healthc. 2021, 14, 2923–2930. [Google Scholar] [CrossRef]
- Costa, D.; Gonçalves, H.A.; De Peraro Lima, L.; Ike, D.; Cancelliero, K.M.; de Lima Montebelo, M.I. New Reference Values for Maximal Respiratory Pressures in the Brazilian Population. J. Bras. Pneumol. 2010, 36, 306–312. [Google Scholar] [CrossRef]
- Simões, R.P.; Deus, A.P.L.; Auad, M.A.; Dionísio, J.; Mazzonetto, M.; Borghi-Silva, A. Maximal respiratory pressure in healthy 20 to 89 year-old sedentary individuals of central São Paulo State. Braz. J. Phys. Ther. 2010, 14, 60–67. [Google Scholar] [CrossRef]
- Gil Obando, L.; López, A.; Avila, C. Normal Values of the Maximal Respiratory Pressures in Healthy People Older than 20 Years Old in the City of Manizales-Colombia. Colomb. Médica 2012, 43, 119–125. [Google Scholar] [CrossRef]
- Moeliono, M.; Sari, D.M.; Nashrulloh, T. Prediction for the maximum inspiratory pressure value from the thoracic expansion measurement in Indonesian healthy young adults. Can. J. Respir. Ther. 2022, 58, 34–38. [Google Scholar] [CrossRef] [PubMed]
- Park, T.S.; Tak, Y.J.; Ra, Y.; Kim, J.; Han, S.H.; Kim, S.H.; Shin, Y.; Shin, M.-J.; Kang, J.H. Reference Respiratory Muscle Strength Values and a Prediction Equation Using Physical Functions for Pulmonary Rehabilitation in Korea. J. Korean Med. Sci. 2023, 38, e325. [Google Scholar] [CrossRef]
- Sriboonreung, T.; Leelarungrayub, J.; Yankai, A.; Puntumetakul, R. Correlation and Predicted Equations of MIP/MEP from the Pulmonary Function, Demographics and Anthropometrics in Healthy Thai Participants aged 19 to 50 Years. Clin. Med. Insights Circ. Respir. Pulm. Med. 2021, 15, 11795484211004494. [Google Scholar] [CrossRef] [PubMed]
- Johan, A.; Chan, C.C.; Chia, H.P.; Chan, O.Y.; Wang, Y.T. Maximal respiratory pressures in adult Chinese, Malays and Indians. Eur. Respir. J. 1997, 10, 2825–2828. [Google Scholar] [CrossRef]
- Ceriotti, F.; Hinzmann, R.; Panteghini, M. Reference intervals: The way forward. Ann. Clin. Biochem. 2009, 46, 8–17. [Google Scholar] [CrossRef]
- Epidemiology & Disease Control Division M of HS, Institute for Health Metrics and Evaluation. The Burden of Disease in Singapore, 1990–2017: An Overview of the Global Burden of Disease Study 2017 Results. 2019. Available online: https://www.moh.gov.sg/others/resources-and-statistics/singapore-burden-of-disease-report-2017 (accessed on 7 August 2025).
- Graham, B.L.; Steenbruggen, I.; Miller, M.R.; Barjaktarevic, I.Z.; Cooper, B.G.; Hall, G.L.; Hallstrand, T.S.; Kaminsky, D.A.; McCarthy, K.; McCormack, M.C.; et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am. J. Respir. Crit. Care Med. 2019, 200, e70–e88. [Google Scholar] [CrossRef] [PubMed]
- Agency for Care Effectiveness (ACE). Supplementary Guide: Open-Access Spirometry in Singapore. ACE Clinical Guidance (ACG), Ministry of Health, Singapore. 3 June 2024. Available online: https://isomer-user-content.by.gov.sg/68/654eaf8e-6356-438d-8bdc-62fa4fa977e8/supplementary-guide-on-open-access-spirometry-in-singapore-(june-2024).pdf (accessed on 9 August 2025).
- Harik-Khan, R.I.; Wise, R.A.; Fozard, J.L.; Harik-Khan, R. Determinants of Maximal Inspiratory Pressure The Baltimore Longitudinal Study of Aging. Am. J. Respir. Crit. Care Med. 1998, 158, 1459–1464. [Google Scholar] [CrossRef] [PubMed]
- Thomas, E.T.; Guppy, M.; Straus, S.E.; Bell, K.J.L.; Glasziou, P. Rate of normal lung function decline in ageing adults: A systematic review of prospective cohort studies. BMJ Open 2019, 9, e028150. [Google Scholar] [CrossRef] [PubMed]
- Agusti, A.; Faner, R. Lung function trajectories in health and disease. Lancet Respir. Med. 2019, 7, 358–364. [Google Scholar] [CrossRef]
- Warburton, D.E.R.; Jamnik, V.K.; Bredin, S.S.D.; Gledhill, N. The physical activity readiness questionnaire for everyone (PAR-Q+) and electronic physical activity readiness medical examination (ePARmed-X+). Health Fit. J. Can. 2011, 4, 3–17. [Google Scholar]
- Borson, S.; Scanlan, J.; Brush, M.; Vitaliano, P.; Dokmak, A. The Mini-Cog: A cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int. J. Geriatr. Psychiatry 2000, 15, 1021–1027. [Google Scholar] [CrossRef]
- WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363, 157–163. [Google Scholar] [CrossRef]
- Pauwels, R.A.; Buist, S.; Calverley, P.M.A.; Jenkins, C.; Hurd, S.S. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2001, 163, 1256–1276. [Google Scholar] [CrossRef]
- Deurenberg, P.; Weststrate, J.A.; Seidell, J.C. Body Mass Index as a Measure of Body Fatness: Age-and Sex-Specific Prediction Formulas. Br. J. Nutr. 1991, 65, 105–114. [Google Scholar] [CrossRef]
- Debouche, S.; Pitance, L.; Robert, A.; Liistro, G.; Reychler, G. Reliability and Reproducibility of Chest Wall Expansion Measurement in Young Healthy Adults. J. Manip. Physiol. Ther. 2016, 39, 443–449. [Google Scholar] [CrossRef]
- Barrios, P.; Martin-Biggers, J.; Quick, V.; Byrd-Bredbenner, C. Reliability and criterion validity of self-measured waist, hip, and neck circumferences. BMC Med. Res. Methodol. 2016, 16, 49. [Google Scholar] [CrossRef] [PubMed]
- Terzano, C.; Ceccarelli, D.; Conti, V.; Graziani, E.; Ricci, A.; Petroianni, A. Maximal respiratory static pressures in patients with different stages of COPD severity. Respir. Res. 2008, 9, 8. [Google Scholar] [CrossRef] [PubMed]
- Melén, E.; Faner, R.; Allinson, J.P.; Bui, D.; Bush, A.; Custovic, A.; Garcia-Aymerich, J.; Guerra, S.; Breyer-Kohansal, R.; Hallberg, J.; et al. Lung-function trajectories: Relevance and implementation in clinical practice. Lancet 2024, 403, 1494–1503. [Google Scholar] [CrossRef] [PubMed]
- Alison McConnell. Respiratory Muscle Training: Theory and Practice; Elsevier Health Sciences: Amsterdam, The Netherlands, 2013. [Google Scholar]
- Severin, R.; Franz, C.K.; Farr, E.; Meirelles, C.; Arena, R.; Phillips, S.A.; Bond, S.; Ferraro, F.; Faghy, M. The effects of COVID-19 on respiratory muscle performance: Making the case for respiratory muscle testing and training. Eur. Respir. Rev. 2022, 31, 220006. [Google Scholar] [CrossRef]



| Variables | Total (n = 391) | Female (n = 202) | Male (n = 189) | p-Value | Rank- Biserial Correlation |
|---|---|---|---|---|---|
| Age, years | 26.0 (23.5 to 36.0) | 25.5 (23.0 to 36.8) | 26.0 (24.0 to 35.0) | 0.052 | 0.10 |
| Height, cm | 165 (160 to 172) | 160 (156 to 165) | 172 (167 to 176) | <0.001 | 0.70 |
| Weight, kg | 60.3 (53.6 to 70.1) | 54.5 (50.4 to 59.8) | 69.3 (61.7 to 75.8) | <0.001 | 0.66 |
| BMI, kg/m2 | 22.0 (20.3 to 24.4) | 21.2 (19.8 to 22.8) | 23.4 (21.5 to 25.2) | <0.001 | 0.36 |
| Race, n (%) | |||||
| Chinese | 358 (91.5) | 192 (49.1) | 166 (42.4) | ||
| Malay | 18 (4.6) | 7 (1.8) | 11 (2.8) | ||
| Indian | 7 (1.8) | 1 (0.3) | 6 (1.5) | ||
| Eurasian | 1 (0.3) | 1 (0.3) | 0 (0.0) | ||
| Others: | 7 (1.8) | 1 (0.3) | 6 (1.5) | ||
| COVID-19, occurrences | 1 (1 to 1) | 1 (1 to 1.8) | 1 (1 to 1) | 0.945 | 0.00 |
| Days since the last COVID-19 infection | 437 (219 to 595) | 448 (203 to 596) | 428 (236 to 594) | 0.887 | 0.01 |
| Chest circumference (axilla), cm | 4.4 (3.3 to 5.5) | 4.4 (3.2 to 5.4) | 4.5 (3.3 to 5.6) | 0.574 | 0.03 |
| Chest circumference (xiphoid), cm | 5.6 (4.1 to 7.0) | 5.4 (3.8 to 6.7) | 5.9 (4.4 to 7.5) | 0.004 | 0.14 |
| Waist–hip ratio | 0.8 (0.8 to 0.9) | 0.8 (0.7 to 0.8) | 0.8 (0.8 to 0.9) | <0.001 | 0.39 |
| FVC, litres | 3.6 (3.1 to 4.3) | 3.2 (2.9 to 3.5) | 4.3 (3.8 to 4.8) | <0.001 | 0.71 |
| FEV1, litres | 3.2 (2.7 to 3.7) | 2.8 (2.5 to 3.1) | 3.7 (3.4 to 4.1) | <0.001 | 0.69 |
| FEV1/FVC% | 88 (84 to 91) | 89 (85 to 91.8) | 86 (82 to 91) | 0.692 | 0.02 |
| PEF | 7.3 (6.2 to 9.0) | 6.3 (5.5 to 7.1) | 9.0 (7.9 to 10.0) | <0.001 | 0.72 |
| PEF25–75% | 3.6 (3.0 to 4.3) | 3.3 (2.9 to 3.9) | 4.2 (3.3 to 5.0) | <0.001 | 0.42 |
| MIP, cmH2O | 94 (72 to 121) | 83 (65 to 103) | 112 (88 to 132) | <0.001 | 0.40 |
| MEP, cmH2O | 74 (61 to 88) | 64 (56 to 75) | 85 (72 to 106) | <0.001 | 0.54 |
| Age Group | MIP, cmH2O | p-Value | MEP, cmH2O | p-Value |
|---|---|---|---|---|
| 20 to 24 | ||||
| Female (n = 88) | 86.0 (66.8 to 103.3) | <0.001 | 66.0 (56.0 to 77.0) | <0.001 |
| Male (n = 59) | 118.0 (98.5 to 147.0) | 88.0 (73.5 to 109.5) | ||
| 25 to 29 | ||||
| Female (n = 38) | 89.5 (73.0 to 111.0) | <0.001 | 67.0 (55.8 to 78.0) | <0.001 |
| Male (n = 63) | 114.0 (89.0 to 134.0) | 83.0 (71.5 to 102.5) | ||
| 30 to 39 | ||||
| Female (n = 29) | 73.0 (55.0 to 88.0) | <0.001 | 63.0 (57.0 to 73.0) | <0.001 |
| Male (n = 29) | 113.0 (93.0 to 126.0) | 87.0 (73.0 to 103.0) | ||
| 40 to 49 | ||||
| Female (n = 18) | 93.0 (71.3 to 109.8) | <0.001 | 68.5 (56.3 to 85.0) | <0.001 |
| Male (n = 15) | 99.0 (78.5 to 123.0) | 91.0 (74.0 to 109.5) | ||
| 50 to 59 | ||||
| Female (n = 17) | 68.0 (54.0 to 93.0) | <0.001 | 61.0 (54.0 to 65.0) | <0.001 |
| Male (n = 10) | 80.0 (64.5 to 130.0) | 78.5 (69.5 to 84.0) | ||
| >60 | ||||
| Female (n = 12) | 65.0 (51.3 to 75.3) | <0.001 | 57.0 (50.5 to 64.3) | <0.001 |
| Male (n = 13) | 87.0 (53.0 to 122.0) | 82.0 (77.0 to 105.0) |
| Variables | Maximum Inspiratory Pressure | Maximum Expiratory Pressure | ||||
|---|---|---|---|---|---|---|
| r | 95% CI | p-Value | r | 95% CI | p-Value | |
| Gender | −0.399 | −0.482 to −0.310 | <0.001 | −0.537 | −0.606 to −0.460 | <0.001 |
| Age, years | −0.149 | −0.247 to −0.0476 | 0.003 | −0.022 | −0.124 to 0.080 | 0.660 |
| Height, cm | 0.307 | 0.212 to 0.397 | <0.001 | 0.368 | 0.276 to 0.453 | <0.001 |
| Weight, kg | 0.412 | 0.323 to 0.493 | <0.001 | 0.455 | 0.370 to 0.532 | <0.001 |
| BMI, kg/m2 | 0.356 | 0.264 to 0.442 | <0.001 | 0.362 | 0.270 to 0.448 | <0.001 |
| Days since the last COVID-19 infection | −0.0632 | −0.175 to 0.050 | 0.260 | −0.031 | −0.143 to 0.082 | 0.580 |
| Chest circumference (axilla), cm | 0.187 | 0.086 to 0.283 | <0.001 | 0.078 | −0.025 to 0.178 | 0.130 |
| Chest circumference (xiphoid), cm | 0.209 | 0.109 to 0.305 | <0.001 | 0.152 | 0.050 to 0.250 | 0.003 |
| Waist–hip ratio | 0.202 | 0.102 to 0.298 | <0.001 | 0.292 | 0.195 to 0.382 | <0.001 |
| FVC, litres | 0.408 | 0.319 to 0.489 | <0.001 | 0.420 | 0.332 to 0.500 | <0.001 |
| FEV1, litres | 0.404 | 0.315 to 0.486 | <0.001 | 0.407 | 0.318 to 0.488 | <0.001 |
| PEF | 0.509 | 0.429 to 0.581 | <0.001 | 0.544 | 0.468 to 0.612 | <0.001 |
| PEF25–75% | 0.229 | 0.072 to 0.374 | 0.004 | 0.270 | 0.116 to 0.411 | <0.001 |
| MIP = 257.1 − 23.4 (Female = 1; Male = 0) − 0.72 (Age, Year) − 1.27 (Height, cm) + 1.41 (Weight, kg) | ||||
|---|---|---|---|---|
| R2 = 27.5% | Coefficient | Standard Error | p-Value | 95% CI |
| Constant | 257.1 | 46.51 | <0.001 | 165.6 to 348.5 |
| Gender | −23.4 | 4.33 | <0.001 | −31.9 to −14.9 |
| Age, year | −0.72 | 0.13 | <0.001 | −0.97 to −0.47 |
| Height, cm | −1.27 | 0.31 | <0.001 | −1.88 to −0.67 |
| Weight, kg | 1.41 | 0.23 | <0.001 | 0.97 to 1.86 |
| MEP = 146.8 − 20.1 (female = 1; male = 0) − 0.20(Age, year) − 0.63(Height, cm) + 0.83(Weight, kg) | ||||
| R2 = 32.1 | Coefficient | Standard error | p-value | 95% CI |
| Constant | 146.8 | 30.35 | <0.001 | 87.2 to 206.5 |
| Gender | −20.1 | 2.82 | <0.001 | −25.7 to −14.6 |
| Age, year | −0.20 | 0.08 | =0.010 | −0.36 to −0.04 |
| Height, cm | −0.63 | 0.20 | =0.002 | −1.02 to −0.23 |
| Weight, kg | 0.83 | 0.15 | <0.001 | 0.54 to 1.12 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Huang, K.S.; Roslan, F.D.B.; Cheong, H.H.; Woo, J.J.; Tan, K.W.; Swee, K.; Liang, S.-Y.; Lau, W.X.; Yeung, M.T. Maximal Respiratory Muscle Strength in Singaporean Adults: Normative Reference Values and Predictive Models from a Cross-Sectional Study. Muscles 2025, 4, 47. https://doi.org/10.3390/muscles4040047
Huang KS, Roslan FDB, Cheong HH, Woo JJ, Tan KW, Swee K, Liang S-Y, Lau WX, Yeung MT. Maximal Respiratory Muscle Strength in Singaporean Adults: Normative Reference Values and Predictive Models from a Cross-Sectional Study. Muscles. 2025; 4(4):47. https://doi.org/10.3390/muscles4040047
Chicago/Turabian StyleHuang, Katherin S., Filzah Diana Binte Roslan, Hong Hin Cheong, Jeremy J. Woo, Kian Wee Tan, Kim Swee, Shu-Ying Liang, Wei Xi Lau, and Meredith T. Yeung. 2025. "Maximal Respiratory Muscle Strength in Singaporean Adults: Normative Reference Values and Predictive Models from a Cross-Sectional Study" Muscles 4, no. 4: 47. https://doi.org/10.3390/muscles4040047
APA StyleHuang, K. S., Roslan, F. D. B., Cheong, H. H., Woo, J. J., Tan, K. W., Swee, K., Liang, S.-Y., Lau, W. X., & Yeung, M. T. (2025). Maximal Respiratory Muscle Strength in Singaporean Adults: Normative Reference Values and Predictive Models from a Cross-Sectional Study. Muscles, 4(4), 47. https://doi.org/10.3390/muscles4040047

